InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (7 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
7
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Conroy Kevin T, Chief Executive Officer and Chairman of the Board. Director active across 6 companies, notably Exact Sciences CORP. Cumulatively, 56 disclosures have been recorded. Breakdown: 1 buy · 7 sells. Total volume traded: €9.1m. History available since 30 April 2021. The latest transaction was filed on 20 May 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Conroy Kevin T
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations56 total
1,745 shares0Common StockSEC:0001193125-26-237321:0
2,286 shares0Common shares without par valueSEC:0001306119-26-000004:0
119,312 shares0Common StockSEC:0001193125-26-118755:0
18,143 shares0Common StockSEC:0001193125-26-089303:0
13,181 shares0Common StockSEC:0001193125-26-082828:0
244,931 shares0Common StockSEC:0001193125-25-337153:0
1,148 shares0Common StockSEC:0001415889-25-014232:0
66,723 shares@ US$22.386.3% of flowCommon StockSEC:0000950170-25-036484:0
18,143 shares0Common StockSEC:0000950170-25-032293:0
13,180 shares0Common StockSEC:0000950170-25-028163:0
10,374 shares0Common StockSEC:0000950170-25-024896:0
19,500 shares@ US$51.354.3% of flowCommon StockSEC:0000950170-24-126119:0
Canonical exit: 11 Feb 2025 (T+90)
660 shares0Common StockSEC:0001415889-24-014460:0
2,489 shares0Common StockSEC:0000950170-24-052390:0
18,143 shares0Common StockSEC:0001209191-24-004236:0
13,181 shares0Common StockSEC:0001209191-24-004078:0
102,837 shares@ US$13.966.0% of flowCommon StockSEC:0001209191-24-003944:0
23,238 shares0Common StockSEC:0001209191-24-003918:0
10,374 shares0Common StockSEC:0001209191-24-003867:0
709 shares@ US$30.020.1% of flowCommon StockSEC:0001209191-24-003463:0
14,775 shares0Common StockSEC:0001062993-23-006332:0
13,180 shares0Common StockSEC:0001209191-23-014239:0
10,374 shares0Common StockSEC:0001209191-23-012207:0
31,132 shares0Common StockSEC:0001209191-23-010133:0
9,705 shares0Common StockSEC:0001209191-23-009301:0
25 of 56 declarations
About Conroy Kevin T
Conroy Kevin T is Chief Executive Officer and Chairman of the Board. He has 56 filings in total, and within the sampled recent filings the buy and sell amounts are EUR 943158 and EUR 8173893, with a date range from 2016-01-05 to 2026-05-22. His filings concern Exact Sciences CORP, where he is President and CEO, as well as Epizyme, Inc., Align Technology INC, Adaptive Biotechnologies Corp, Abbott Laboratories, and SomaLogic, Inc., where he is Director.
